Cargando…
Upregulation of prolylcarboxypeptidase (PRCP) in lipopolysaccharide (LPS) treated endothelium promotes inflammation
BACKGROUND: Prolylcarboxypeptidase (Prcp) gene, along with altered PRCP and kallikrein levels, have been implicated in inflammation pathogenesis. PRCP regulates angiotensin 1–7 (Ang 1–7) – and bradykinin (BK) – stimulated nitric oxide production in endothelial cells. The mechanism through which kall...
Autores principales: | Ngo, My-Linh, Mahdi, Fakhri, Kolte, Dhaval, Shariat-Madar, Zia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639534/ https://www.ncbi.nlm.nih.gov/pubmed/19171072 http://dx.doi.org/10.1186/1476-9255-6-3 |
Ejemplares similares
-
Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment
por: Shariat-Madar, B, et al.
Publicado: (2010) -
Daniel Whistler, PRCP
por: Cooke, A. M.
Publicado: (1967) -
Prolylcarboxypeptidase Mitigates Myocardial Ischemia/Reperfusion Injury by Stabilizing Mitophagy
por: Hao, Panpan, et al.
Publicado: (2020) -
Potential Benefits of Antioxidant Phytochemicals in Type 2 Diabetes
por: Arabshomali, Arman, et al.
Publicado: (2023) -
The papers of Sir Thomas Barlow, BT, KCVO, FRS, PRCP (1845-1945).
por: Aspin, R K
Publicado: (1993)